<DOC>
	<DOC>NCT00257582</DOC>
	<brief_summary>To assess the safety of long-term use of cetirizine dry syrup in children with various type of cutaneous disease accompanied on pruritus.</brief_summary>
	<brief_title>Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics</brief_title>
	<detailed_description />
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Chronic urticaria Eczema &amp; dermatitis group Atopic dermatitis Prurigo group: Acute prurigo, Prurigo subacuta, Chronic prurigo Pruritus cutaneous: Systemic pruritus cutaneous, Topical pruritus cutaneous Giving informed consent Children who have 2 grades or more pruritus score when assessed by the investigator or subinvestigator with the criteria for the diurnal or nocturnal pruritus score in the patient diary. Children with a pruritus severity of "2.Mild" or severer on the first day of the treatment period. Exclusion criteria: have a history of drug hypersensitivity are pregnant, lactating or possibly pregnant female children. have asthma that requires the treatment with corticosteroid. cannot avoid the use of external steroid classified into "strong", "strongest" or "very strong". have pruritus only on face and head. have inappropriate complication of dermal disorder that may influence on the evaluation of the study drug. are undergoing specific desensitization therapy or immunomodulation therapy or phototherapy.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>cetirizine</keyword>
	<keyword>various type of cutaneous disease accompanied with Pruritus</keyword>
	<keyword>pediatrics</keyword>
</DOC>